







and Supplementation in Chronic Online
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Institute, Epalinges, SwitzerlandIntroduction: Supplementation of water-soluble vitamins is a common practice in hemodialysis patients,
but dosages are largely based on conventional hemodialysis techniques. The aim of this study was to
assess the status of water-soluble vitamins in patients on hemodiafiltration (HDF), and attempt to deter-
mine optimal dose of vitamin supplements.
Methods: This monocentric study included 40 patients on thrice-weekly chronic HDF. At baseline, all pa-
tients received 2 tablets of Dialvit containing B and C vitamins after each dialysis session. Predialysis
samples of B and C vitamins were measured in both blood (n ¼ 40) and a subgroup of dialysate (n ¼ 6)
samples. A second blood sample was obtained in 24 patients 3 months after dose adjustment of the
vitamin supplement.
Results: At baseline, B-vitamin levels were high with, respectively, 0.4%, 10.0%, and 89.6% of patients in
the low, normal, and high reference range. For vitamin C, most patients were in the normal range (5.0%,
82.5%, and 12.5% in low, normal, and high reference range). Three months after dose reduction, B vitamin
levels decreased but stayed mostly at or above the normal range (1.4%, 25.7%, 72.9% in low, normal, and
high reference range). Three patients (12.5%) developed vitamin C deficiency on low-dose substititon.
Conclusion: This study shows that the levels of most vitamins are above the normal range in patients on
HDF receiving a classic dose of vitamin supplements, vitamin C excepted. Our study suggests that the
classic dose of postdialysis vitamin B supplements may be reduced.
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emodialysis is a life-saving technique that removes
uremic toxins and restores acid-base, fluid, and
electrolyte homeostasis. Worldwide, the past decade
has witnessed a trend toward increased use of high-
flux filters and HDF. This technique is more effective
in the removal of middle-sized molecules than conven-
tional hemodialysis (CHD), and possibly improves sur-
vival if large convective volumes are achieved.1
However, HDF may lead to increased losses of essential
substances such as albumin and micronutrients.2 He-
modialysis patients are also at risk for water-soluble
vitamin deficiencies. Indeed, due to their low molecularspondence: Menno Pruijm, Service of Nephrology and Hy-
sion, Lausanne Unversity Hospital (CHUV), Rue du Bugnon
11 Lausanne, Switzerland. E-mail: menno.pruijm@chuv.ch
ved 10 March 2020; revised 3 September 2020; accepted 8
mber 2020; published online 12 September 2020weight (<1 kDa), losses of such vitamins may occur
during hemodialysis sessions. Besides, absolute and
functional vitamin deficiencies can result from malnu-
trition, diminished gastrointestinal absorption, and
abnormal renal metabolism in the hemodialysis popula-
tion.3,4 Water-soluble vitamin supplementation has
therefore become a common practice in chronic hemo-
dialysis patients.5 Nevertheless, prophylactic vitamin
supplementation is heterogeneous within and across
countries,6 ranging from 4% in the United Kingdom
to 72% in the United States, possibly because official
guidelines are lacking or contradictive (Kidney Disease
Improving Global Outcomes,7 Kidney Disease Out-
comes Quality Initiative,8 Best Practice guidelines3). If
vitamins are provided during dialysis sessions, it is
usually a combination of B-group vitamins and vitamin
C (ascorbic acid). Moreover, vitamin supplementation
doses and schedules are largely based on studies per-
formed in patients on CHD.9 Despite a few studies on
vitamins C, B9 (folic acid), and vitamin B12Kidney International Reports (2020) 5, 2160–2167
N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltration CLINICAL RESEARCH(cobalamin),10–15 there is a lack of knowledge specific to
HDF-associated losses of water-soluble vitamins.
Although water-soluble vitamins are relatively small
molecular weight molecules, losses are possibly higher
in HDF as compared with CHD. Morena et al.14 re-
ported a reduction in circulating vitamin C of 45%
(8–230 mg) and 30% per session in HDF and CHD,
respectively. Diffusive transport was responsible for
two-thirds, whereas convection accounted for up to
30% of the loss of vitamin C. As the convective volume
was relatively low (maximal 15 liters) compared with
current practice, one may expect even greater losses
in the clinical setting. Besides, water-soluble vitamins
are partly bound to albumin,16 and albumin losses
occur more often in HDF.2 To the best of our knowl-
edge, there are no data concerning dialysate losses of
vitamins B2 (riboflavin), B3 (niacin), B5 (pantothenic
acid), B6 (pyridoxine), and B8 (biotine or B7) in HDF.
As a consequence, the optimal vitamin supplementa-
tion regimen for patients with chronic HDF remains
largely unknown.
The aims of this study were therefore (i) to assess the
status of water-soluble vitamins in patients with
chronic hemodialysis receiving HDF and vitamin sup-
plements, (ii) to quantify vitamin losses during HDF,
and (iii) to assess what could be the optimal dose of
vitamin supplements in patients with HDF.
METHODS
This monocentric study was approved by the local
ethics committee of the Canton de Vaud, Switzerland
(Swissethics CER-VD, ID-Nr 2017–00518) and con-
ducted according to the principles expressed in the
Declaration of Helsinki. Written informed consent was
obtained from all participants before entry into the
study.
Subjects’ Characteristics and Study Protocol
All 80 patients undergoing dialysis at the outpatient
dialysis clinic of the University Hospital in Lausanne
were screened for the study. In Lausanne, as in many
other Swiss dialysis centers, patients receive a fixed
dose of vitamin supplements after each dialysis session
(typically 2 tablets of Dialvit; each tablet of Dialvit
contains 50 mg of vitamin B1, 10 mg of vitamin B2, 40
mg of vitamin B6, 3 mg of vitamin B9, and 200 mg of
vitamin C). When translated to % daily recommended
doses (%DRD), this corresponds to 4348% for vitamin
B1, 834% for vitamin B2, 400% of vitamin B6, 300%
for vitamin B9, and 222% of vitamin C.
Patients undergoing CHD were excluded from the
study. Inclusion criteria were age$18 years and ability
to provide informed consent. Exclusion criteria were
concomitant treatment with iron binders, or regularKidney International Reports (2020) 5, 2160–2167use of self-medication with vitamins, minerals, and
food supplements.
Baseline Vitamin Status
After informed consent, the vitamin status was evalu-
ated in patients with HDF by measuring the predialysis
vitamin concentrations on the day of their monthly
laboratory check. Two 7.5-ml heparinized blood sam-
ples (Sarstedt) were collected; the samples were pro-
tected from light, immediately stored on ice, and
centrifuged (Eppendorf Centrifuge 5702 R, Hamburg,
Germany) within an hour at 2318 relative centrifugal
force for 10 minutes at 4C. Serum was collected in a 2-
ml tube (Sarstedt, Micro tube 2 ml) and stored at 80C
before being transferred to the Swiss Vitamin Institute
of Epalinges for vitamin analysis. Plasma vitamin C was
measured by high-performance liquid chromatography
with an electrochemical detector.17 Vitamins B1, B2, B5,
B6, B8, and B9 concentrations were measured with
functional assays routinely performed in the laboratory
using adapted microbiologic methods on microplates
with different bacterial strains.17
Vitamin Losses Throughout a Hemodialfiltration
Session
In a subgroup of patients on HDF, we quantified the
amount of vitamin losses during an HDF session using
continuous sampling of spent dialysate.18
Accurate estimation of total vitamin loss in dialysate
(diffusive and convective losses) is ideally performed
by measuring the vitamin concentrations in the total
dialysate effluent volume. In one 240-minute HDF
session, the effluent volume can reach 200 liters, raising
technical and logistical issues.
Sequential sampling (start, mid-, and end-session) in
the dialysate outflow, as described in literature,14 is
prone to significant error, as dialysate effluent is
collected in an unsteady fashion.
A dialysate separator was then used in this subgroup
of patients. This device allowed us to collect a fraction
(approximately 1%) of the dialysate throughout the
treatment at a constant flow rate. The measurement of
the total amount of the studied vitamines (Total VIT-
dial) being cleared during 1 HDF session is therefore
calculated from a small representative sample.18
Total VITdial was calculated as following: Total
VITdial (nmol or mg) ¼ [TotVIT]  TotDIAL, where
[TotVIT] is the concentration of a particular vitamine
in total spent dialysate (in nmol/L, mg/L) and TotDIAL
is the total volume of spent dialysate (in liters). Tot-
DIAL is further defined as: TotDIAL (liters) ¼ Dialysate
Flow Rate [l/min]  dialysis duration [min] þ total
convective volume (liters). The total convective volume
corresponds to the total postdilutional online2161
Table 1. Patient characteristics
Clinical characteristics Mean ± SD or n (%)
Age (y) 56.1  15.7




CLINICAL RESEARCH N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltrationreinjection volume þ ultrafiltration volume dedicated
to weight loss.
Vitamins B1, B2, B5, B6, B8, and B9 were dosed in
the effluent fluid. Vitamin C was not measured because
vitamin C is degraded when exposed to UV light and
opaque tubing could not be garanteed during the 4-
hour collection process.Asian 5 (12.5)
South American 1 (2.5)
Weight (postdialysis) (kg) 73.07  14.3
Height (cm) 168.6  9.1
Body mass index (kg/m2) 26.4  5.3
Former transplantation (%) 6 (15)
Charlson comorbidity index 5  2.4
Diabetes (%) 16 (40)
Hypertension (%) 31 (77.5)
Vascular acces (%)
Native arteriovenous graft 11 (27.5)
Prosthetic arteriovenous graft 18 (45)Second Vitamin Screening 3 Months After
Adaptation of Vitamin Supplements
After the first phase, vitamin dose was adapted ac-
cording to the results of the baseline visit. After 3
months of dose adaptation, a second predialysis follow-
up blood sample of vitamin status was mesured in
patients who had not been hospitalized or suffered of
any intercurrent illness. The same methods as
described previously were applied.Permanent hemodialyis catheter 11 (27.5)
Dialyzer F  1000 (%) 35 (87.5)
Weekday (Monday) (%) 22 (55)
Hemodiafiltration vintage (mo) 15.6  17.6
Sp kt/V; ekt/V 1.8  0.3; 1.6  0.3
Blood flow (ml/min) 361  31
Weekly dialysis time (min) 711  27
Substution volume (liters) 22.0  6.2
Epurated blood volume (liters) 84.9  9.4
Ultrafiltration (ml) 2012  1065Parameters
The spKt/V was calculated with the Daugirdas for-
mula.19 Normalized polymerase chain reaction (nPCR)
was used to reflect protein catabolism and intake, and
calculated using interdialytic urea kinetics.20
Dialysis vintage was defined as the time between the
start of renal replacement therapy and the baseline
visit. HDF vintage was the time between the intro-
duction of this specific treatement method and the
baseline visit. Blood flow was the average blood flow of
the dialysis session on the sampling day. Substitution
volume was the postdilutional online reinjection vol-
ume on the day of the study visit. Epurated blood
volume was the total volume of blood treated by 1 HDF
session and equaled the blood flow  dialysis time.
Ultrafiltration volume was the net filtered volume
dedicated to the adequate control of the patient volume
condition. Charlson comorbidity index was calculated
based on comorbidity data obtained from a chart
review.21Statistical Analysis
Values of the whole group are given as means and their
SDs, or as median (interquartile range), as appropriate.
Circulating vitamin levels were compared with the
standard reference range of the general population as
published by Schupbach et al.22 To compare the means
before and after a dialysis session or of the effluent
volume, we used analysis of variance for repeated
measures. Further pairwise comparisons were carried
out using Student’s t-test or Fisher’s least significant
difference. Associations between circulating vitamin
levels and several baseline characteristics were assessed
using Spearman’s rank correlation. All P values are 2-
sided and values < 0.05 were considered to be2162significant. Analyses were performed using STATA
software version 12.1 (StataCorp, College Station, TX).
RESULTS
A total of 40 patients on chronic HDF were enrolled in
the study. Patient and dialysis characteristics are listed
in Table 1.
Results of baseline laboratory values (electrolytes,
creatinine, urea, and proteins) are shown in
Supplementary Table S1. Concerning potassium and
phosphate, most patients (90% and 70%, respectively)
were within the range recommended by the Kidney
Disease Improving Global Outcomes guidelines. Mean
nPCR value was 1.07  0.27 g/kg per day, suggesting
sufficient protein intake.
Results of the different predialysis hydrosoluble
vitamin concentrations are listed in Table 2. The large
majority of patients were above the normal reference
intervals for B vitamins (B1, B2, B5, B6, B8, B9) with
0.4%, 10.0%, and 89.6% in the low, normal, and high
reference range, respectively. For vitamin C, most pa-
tients were in the range that is considered normal for
the healthy population,22 with 5.0%, 82.5%, and
12.5% in the low, normal, and high reference range.
Only 2 patients showed vitamin levels below the
reference range: one patient for vitamin C and the otherKidney International Reports (2020) 5, 2160–2167
Table 2. Predialysis vitamin concentrations
Vitamin Ref range Mean (SD) Deficient
Normal
Highn (%)
Vitamin B1a 10–53 (nmol/l) 207.8 (138.2) – 4 (10) 36 (90)
Vitamin B2a 18–180 (nmol/l) 257.7 (143.7) – 10 (25) 30 (75)
Pantothenic acid 160–588 (nmol/l) 1515.6 (1321.5) – 2 (5) 38 (95)
Vitamin B6a 6.5–69 (nmol/l) (women)
10–111 (nmol/l) (men)
177.3 (65.0) 1 (2.5) 3 (7.5) 36 (90)
Biotin 0.3–3.8 (nmol/l) 7.4 (3.8) – 5 (12.5) 35 (87.5)
Folic acida 7–31 (nmol/l) 169.5 (54.9) – – 40 (100)
Vitamin Ca 26–97 (mmol/l) 64.9 (39.3) 2 (5) 33 (82.5) 5 (12.5)
aSubstituted vitamins.
Predialysis vitamin concentrations measured during the first phase (all patients on 2 tablets of Dialvit postdialysis thrice weekly).
N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltration CLINICAL RESEARCHpatient for vitamins C and B6. When confronted with
these results, the 2 vitamin-deficient patients admitted
not taking the vitamin supplements administered at the
end of each dialysis session.
Vitamin Losses Throughout a Hemodialfiltration
Session
Vitamin losses in the dialysate were measured in 6
patients; all 6 were taking 2 tablets of Dialvit thrice
weekly at the moment of the dialysate collection.
Vitamin blood levels before and after the dialyis session
were obtained (Figure 1). Results of total vitamin losses
in dialysate are reported in Table 3. Data are repre-
sented as absolute loss (nmol and mg) and related to
food intake as in DRD. Levels of vitamin B2 could not
be measured in 3 samples. Vitamin B8 value was
annulated for 1 sample for technical reasons (abnor-
mally high value). Mean values of blood flow were 375
ml/min ( 42 ml/min), dialysate flow 515 ml/min ( 17
ml/min), substitution volume 16.7 l ( 8.7 l), dialysate
time 230 minutes ( 15 ml/min), and ultrafiltration
1300 ml ( 724 ml). Mean sampling volume was 1541
ml ( 122 ml) of a mean total effluent volume of 139 l
( 10 l), which corresponds to 1.1% of the total
effluent volume (see Supplementary Table S2).
Compared with DRDs of vitamin intake, average
vitamin losses were estimated at 84% of DRD for
vitamin B1, 197% of DRD for vitamin B2, 148% of DRD
for vitamin B5, 37% of DRD for vitamin B8, and 67%
of DRD for vitamin B9. Low dialysis losses were
detected for vitamin B6, estimated at 1% of DRD.
Associations Between Vitamin Status and
Baseline Clinical Characteristics
In univariate analysis (Spearman), there were no asso-
ciations between the levels of circulating vitamins and
basic patient characteristics such as age, gender, and
body mass index. No significant associations were
found between vitamin levels and other patient pa-
rameters, such as weight, Charlson comorbidity index,
hospitalization in the past 3 months, ethnicity, andKidney International Reports (2020) 5, 2160–2167diabetes (with the exception of vitamin B6, rho 0.39,
P ¼ 0.014).
The dialysis parameters Kt/V, substitution volume,
epurated blood volume, and vascular access were also
not associated with vitamin status, except for pan-
thtenic acid that tended to increase with increasing
dialysis vintage (r ¼ 0.39, P ¼ 0.014).
Finally, plasma nutritional parameters showed sig-
nificant associations with some vitamins. Vitamin C was
positively associated with pre-albumin, creatinine, and
urea, as well as a trend toward positive association with
nPCR. Vitamin B6 was positively associated with nPCR,
protein, albumin, and creatinine. Vitamin B5 was
positively associated with nPCR, protein, creatinine,
and urea. Vitamin B8 was positively associated with
pre-albumin and creatinine (summary of associations in
Supplementary Table S3). There were no associations
with dry weight or body mass index. These results
remained unchanged after adjustment for age and sex
in multivariate linerar regression analysis. However,
when applying multiple testing rules (Bonferoni), no
significant associations (P values <0.001) were found.
Dose Supplementation Assessment
A total of 24 patients remained free of complications
between baseline and the 3-month follow-up period.
For the second dose-assessment phase, Dialvit was
reduced to 1 tablet after each session in all patients
with baseline hydrosoluble vitamin levels above
normal range. After 3 months of this low-dose substi-
tution, a follow-up blood sample of vitamin status was
measured (see Table 4). B vitamin levels were lower but
mostly stayed above the normal range (1.4%, 25.7%,
and 72.9% in low, normal, and high reference range).
However, 3 patients (12.5%) had developped vitamin C
deficiency on low-dose substititon (87.5% in normal
range). Comparison of the vitamin levels are displayed
in Figure 2; significant reductions occured in the con-
centrations of vitamins C, B1, B6, B8, and B9. There was
no significant change for vitamins B2 and B5. Vitamin
B2 levels were stable despite supplementation. Of the 22163
Figure 1. Vitamin loss throughout a HDF session (before and after blood levels).
CLINICAL RESEARCH N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltrationother vitamins that were not supplemented, B5 levels
were stable, but suprisingly B8 was lower at the follow-
up measurement. Three patients developed vitamin C
deficiency; 1 patient developed vitamin B1 and B8
deficiency.
The 3 patients who developed vitamin C deficiency
were all in a stable clinical condition and otherwise
good nutritional status; however, 1 patient suffered
from uncontrolled hyperthyroidism and another suf-
fered from alcoholic hepatic cirrhosis.
The patient who showed deficiency for vitamins B1
and B8 showed severe denutrition at the time of the
second vitamin screening. This patient had undergone
heart transplantation 26 years ago and mecanic aortic
heart valve replacement 4 years before the study. He
had been on hemodialysis for 2 years and experienced 2
episodes of bacterial endocarditis in the past year with
prolonged hospitalizations. At the time of the study, he
was still treated with prophylactic oral amoxicillin. He
had no clinical sign of thiamin deficiency. We have
assessed the effect of circulating amoxicillin, at an
estimated physiological concentration of 33 mg/l, on the
results of vitamin B1 and B8 concentrations as
measured by microbiological assays. In this experi-
ment, despite a noticed downestimation of the vitamin
concentrations due to the inhibitory effect of the
antibiotic on the microbiological assays, this effect isTable 3. Exploratory dialysate loss study
Dialysate loss (mean, SD) nmol
Vitamin B1 3625 (4911) 9
Vitamin B2 6294 (2956) 23
Pantothenic acid 33730 (9682) 73
Vitamin B6 647 (389) 1
Biotin 46 (33) 11
Folic acid 1518 (777) 6
The amount of vitamins removed during 1 dialysis session in a subgroup of 6 patients is sh
recommended doses (DRDs).
2164unlikely to explain on its own the observed deficiencies
of vitamins B1 and B8 in this patient (data not shown).DISCUSSION
This monocentric study in patients on chronic HDF on
thrice-weekly postdialysis vitamin supplementation
showed that under these conditions, HDF is not asso-
ciated with hydrosoluble vitamin deficiency, despite
the removal of considerable amounts in the dialysate.
On the contrary, for most vitamins (B1, B2, B8, B6, B9,
and B5), patients showed vitamin levels higher than the
reference range, except for vitamin C. Vitamin levels
remained within the reference range after lowering the
usual supplementation dose, vitamin C excepted.
To the best of our knowledge, this is the first study
that simultaneously measured a panel of hydrosoluble
vitamins in patients on HDF. Tight regulation of
vitamin status is important, as deficiencies or concen-
trations superior to upper recommended levels can lead
to important clinical consequences. Lack of vitamin B1
may lead to Beriberi or Wernicke encephalopathy,
whereas lack of vitamin B6 is associated with stomati-
tis, glossitis, cheilosis, irritability, confusion, and
depression. Deficiencies are the consequence of either
reduced intake or increased losses during hemodialysis
sessions. In our HDF study, dialysate losses weremg % DRD
Blood level
reduction (%)
61 (1301) 84 (113) 49
67 (1111) 197 (93) 34
87 (2120) 148 (42) 43
09 (66) 1.1 (0.7) 27
.2 (8.1) 37 (27) 12
69 (343) 67 (34) 60
own. Absolute vitamin losses are presentend in nmol and mg and translated to daily
Kidney International Reports (2020) 5, 2160–2167
Table 4. Vitamin values after dose adjustment (1 instead of 2 tablets postdialysis thrice weekly in all remaining participants)
Vitamin Ref range Mean (sd) Deficient
Normal
Highn (%)
Vitamin B1a 10–53 (nmol/l) 112.9 (59.4) 1 (4.2) 4 (16.7) 19 (79.2)
Vitamin B2a 18–180 (nmol/l) 244.3 (133.9) – 11 (45.8) 13 (54.2)
Pantothenic acid 160–588 (nmol/l) 1399.9 (663.1) – 1 (4.2) 23 (95.8)
Vitamin B6a 6.5–69 (nmol/l) (women)
10–111 (nmol/l) (men)
116.9 (30.7) – 10 (41.7) 14 (58.3)
Biotin 0.3–3.8 (nmol/l) 5.0 (3.9) 1 (4.2) 11 (45.8) 12 (50)
Folic acida 7–31 (nmol/l) 94.2 (23.9) – – 24 (100)
Vitamin Ca 26–97 (mmol/l) 39.9 (13.7) 3 (12.5) 21 (87.5) –
aSubstituted vitamins.
N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltration CLINICAL RESEARCHimportant. Compared with the DRDs of vitamin intake,
average vitamin losses during 1 HDF sesison ranged
between 27% DRD for B8 to 113% DRD for vitamin B1.
In contrast, vitamin B6 was hardly removed during
dialysis in our study, with losses estimated at 0.7%
DRD.
The only clinical factors that were moderately
associated with baseline vitamin status were parameters
of poor nutrition status, such as nPCR, pre-albumin,
creatinine, and urea. It is well known that dialysis
patients are at high risk for malnutrition because of
restricted diet, diminished gastrointestinal absorption,
and comorbid conditions; however, associations were
weak and no longer significant after Bonferoni
correction.
The main reason for vitamin deficiency was low
adherence to postdialysis vitamin intake (Dialvit). This
was nicely illustrated by the fact that the only 2 pa-
tients with multiple deficiencies at baseline admitted,
when confronted with the results, that that they did
not take Dialvit. They assured the medical team that
they would swallow the pills at home but instead, they
threw them away. They had no signs of vitamin defi-
ciency, and their results normalized at follow-up once
they started taking Dialvit. This strongly suggests that
vitamin supplementation is essential in HDF.Figure 2. Predialysis vitamin levels at baseline with standard vitamin sub
months of lowered dose vitamin substitution of 1 Dialvit tablet (red).
Kidney International Reports (2020) 5, 2160–2167As hydrosoluble vitamins are predominantely elim-
inated by renal clearance, toxic levels may also occur in
end-stage renal disease in case vitamin supplementation
is excessive. Toxic levels have been described for
vitamin B8, with symptoms such as depression, som-
nolence, hyperesthesia, anorexia, and dermatosis.15,16
In the case of vitamin B6, peripheral neuropathy,
dermatoses, photosensitivity, dizziness, and nausea
have been reported, whereas overdose of vitamin C can
lead to oxalosis. Although no clinical signs of toxicity
were observed, most patients in our study had exces-
sive vitamin levels, strongly suggesting that actual
dosing schedules need revision.
The reduction of Dialvit from 2 to 1 tablet in our
study led to significant lower levels of vitamins B1, B6,
B8, and B9 at the second follow-up visit 3 months later,
whereas levels of vitamins B2 and pantothenic acid did
not change. However, in several patients (12.5%),
vitamin C levels were inferior to the deficiency
threshold. The larger effect on vitamin C is in line with
the work of Morena et al.14 that described one-third of
vitamin C loss was attributed to the convective
component of HDF. These data suggest that the per-
formed dose reduction is a first step in the right di-
rection, but further studies are necessary to assess the
optimal vitamin doses. Ideally, the composition ofstition of 2 Dialvit tablets (blue) and follow-up vitamin levels after 3
2165
CLINICAL RESEARCH N Schwotzer et al.: Water-Soluble Vitamins in Hemodiafiltrationmultivitamin pills should be adapted to the actual
trend of increased use of HDF.
This study has several limitations. First, we included
mainly white patients; therefore, results may be
different for various ethnicities. Second, we did not
obtain information on dietary intake or nutritional
habits. Finally, the number of subjects was relatively
low and we did not include a CHD control group.
Instead, we compared our results with data previously
published in the international litterature; however, the
vitamin levels on standard vitamin supplementation
were systematically above the usual range, except in
patients who did not take Dialvit after their dialysis
sessions. We therefore believe that a greater number of
patients would not have fundamentally changed our
main finding, namely that most levels of hydrosoluble
vitamins are above the normal range under current
vitamin substitution.
Among its strengths we mention that this study is,
to the best of our knowledge, the first to explore
simultaneously a complete panel of hydrosoluble vita-
mins in patients with HDF. These findings were
completed with quantitative dialysate loss of these vi-
tamins. We further prospectively adjusted vitamin
doses to assess optimal dosing regimen.
In conclusion, hydrosoluble vitamin B and/or C
deficiency is rare in patients on HDF and only occurs in
patients who do not take the postdialysis vitamin
substitution. Although many vitamins are partly
cleared by HDF, the actual doses can be safely reduced,
vitamin C excepted. Further studies are necessary to
assess the optimal vitamin substitution dose for pa-
tients on HDF.DISCLOSURE
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Table S1. Predialysis biological values.
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